litlas
Log inCreate account

Christopher T. Ritchlin

Active 1991–2025

Also published as
Christopher T Ritchlin
140
Papers
21,623
Citations
75
h-index
131
i10-index

Citations

Citations per year for Christopher T. Ritchlin1991: 1 citations1992: 4 citations1993: 3 citations1994: 6 citations1995: 4 citations1996: 4 citations1997: 5 citations1998: 10 citations1999: 4 citations2000: 6 citations2001: 6 citations2002: 10 citations2003: 14 citations2004: 36 citations2005: 54 citations2006: 73 citations2007: 72 citations2008: 79 citations2009: 104 citations2010: 75 citations2011: 113 citations2012: 87 citations2013: 87 citations2014: 133 citations2015: 150 citations2016: 178 citations2017: 204 citations2018: 261 citations2019: 726 citations2020: 868 citations2021: 879 citations2022: 693 citations2023: 545 citations2024: 844 citations2025: 462 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,632 citing papers, 19.7% of this breakdownUnited Kingdom: 760 citing papers, 9.2% of this breakdownChina: 569 citing papers, 6.9% of this breakdownGermany: 537 citing papers, 6.5% of this breakdownCanada: 502 citing papers, 6.1% of this breakdownItaly: 476 citing papers, 5.8% of this breakdownFrance: 329 citing papers, 4% of this breakdownNetherlands: 326 citing papers, 3.9% of this breakdownSpain: 271 citing papers, 3.3% of this breakdownSwitzerland: 248 citing papers, 3% of this breakdownJapan: 244 citing papers, 2.9% of this breakdownBelgium: 200 citing papers, 2.4% of this breakdown
0%19.7%Other 26.3%

Institutions

Fields

  • Medicine57.7%
  • Immunology and Microbiology24.9%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Neuroscience0.8%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Dentistry0.4%
  • Other1.8%

Topics

  • Psoriasis: Treatment and Pathogenesis14.2%
  • Spondyloarthritis Studies and Treatments14%
  • Rheumatoid Arthritis Research and Therapies12.5%
  • Autoimmune and Inflammatory Disorders Research4.5%
  • Dermatology and Skin Diseases3.1%
  • Bone Metabolism and Diseases2.2%
  • Other49.5%

Coauthors

All papers

Open in search
  1. Psoriatic Arthritis

    Authors: Christopher T. Ritchlin, Robert A. Colbert, Dafna D. Gladman - New England Journal of Medicine 2017 cited by 1,365

  2. Notch signalling drives synovial fibroblast identity and arthritis pathology

    Authors: Kevin Wei, Ilya Korsunsky, Jennifer L. Marshall, Anqi Gao, Gerald F. Watts, Triin Major, Adam P. Croft, Jordan Watts, Philip Blazar, Jeffrey K. Lange, Thomas S. Thornhill, Andrew Filer, Karim Raza, Laura T. Donlin, Jennifer S. Albrecht, Jennifer H. Anolik, William Apruzzese, Brendan F. Boyce, David L. Boyle, S. Louis Bridges, Jane H. Buckner, Vivian P. Bykerk, Edward F. DiCarlo, James P. Dolan, Thomas Eisenhaure, Gary S. Firestein, Chamith Y. Fonseka, Susan M. Goodman, Ellen M. Gravallese, Peter K. Gregersen, Joel M. Guthridge, María Gutiérrez‐Arcelus, Nir Hacohen, V. Michael Holers, Laura B. Hughes, Lionel B. Ivashkiv, Eddie A. James, Judith A. James, A. Helena Jonsson, Josh Keegan, Stephen Kelly, Yvonne Lee, James A. Lederer, David Lieb, Arthur M. Mandelin, Mandy J. McGeachy, Michael A. McNamara, Joseph Mears, Nida Meednu, Fumitaka Mizoguchi, Larry W. Moreland, Jennifer P. Nguyen, Chad Nusbaum, Akiko Noma, Dana E. Orange, Harris Perlman, Costantino Pitzalis, Javier Rangel‐Moreno, Deepak A. Rao, Mina Rohani‐Pichavant, Christopher T. Ritchlin, William H. Robinson, Karen Salomon-Escoto, Anupamaa Seshadri, Jennifer Seifert, Kamil Slowikowski, Danielle Sutherby, Darren Tabechian, Jason D. Turner, Paul J. Utz, Fan Zhang, Christian W. Siebel, Christopher D. Buckley, Soumya Raychaudhuri, Michael B. Brenner - Nature 2020 cited by 536

  3. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Authors: Josef S Smolen, Monika Schöls, Jürgen Braun, Maxime Dougados, Oliver FitzGerald, Dafna D. Gladman, Arthur Kavanaugh, Robert Landewé, Philip J. Mease, Joachim Sieper, Tanja Stamm, Maarten de Wit, Daniel Aletaha, Xenofon Baraliakos, Neil Betteridge, Filip Van den Bosch, Laura C. Coates, Paul Emery, Lianne S. Gensler, Laure Gossec, Philip Helliwell, Merryn Jongkees, Tore K Kvien, Robert D. Inman, Iain B. McInnes, Mara Maccarone, Pedro Machado, Anna Moltó, Alexis Ogdie, Denis Poddubnyy, Christopher T. Ritchlin, Martín Rudwaleit, Adrian Tanew, Bing Thio, Douglas J. Veale, Kurt de Vlam, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 cited by 676

  4. Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

    Authors: Joseph F. Merola, Robert Landewé, Iain B. McInnes, Philip J. Mease, Christopher T Ritchlin, Yoshiya Tanaka, Akihiko Asahina, Frank Behrens, Dafna D. Gladman, Laure Gossec, Alice B. Gottlieb, Diamant Thaçi, Richard B. Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates - The Lancet 2022 cited by 158

  5. Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition

    Authors: José U. Scher, Alexis Ogdie, Joseph F. Merola, Christopher T. Ritchlin - Nature Reviews Rheumatology 2019 cited by 387

  6. Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial

    Authors: Atul Deodhar, Philip Helliwell, Wolf‐­Henning Boehncke, Alexa P. Kollmeier, Elizabeth C. Hsia, Ramanand A. Subramanian, Xie L. Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang, Christopher T Ritchlin - The Lancet 2020 cited by 322

  7. Psoriatic arthritis from a mechanistic perspective

    Authors: Georg Schett, Proton Rahman, Christopher T. Ritchlin, Iain B. McInnes, Dirk Elewaut, José U. Scher - Nature Reviews Rheumatology 2022 cited by 157

  8. 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis

    Authors: Jasvinder A. Singh, Gordon Guyatt, Alexis Ogdie, Dafna D. Gladman, Chad Deal, Atul Deodhar, Maureen Dubreuil, Jonathan Dunham, M. Elaine Husni, Sarah Kenny, Jennifer Kwan‐Morley, Janice Lin, Paula Marchetta, Philip J. Mease, Joseph F. Merola, Julie Miner, Christopher T. Ritchlin, Bernadette C. Siaton, Benjamin J. Smith, Abby S. Van Voorhees, A. Helena Jonsson, Amit Shah, Nancy Sullivan, Marat Turgunbaev, Laura C. Coates, Alice B. Gottlieb, Marina Magrey, W. Benjamin Nowell, Ana‐Maria Orbai, Soumya M. Reddy, José U. Scher, Evan Siegel, Michael Siegel, Jessica A. Walsh, Amy S. Turner, James Reston - Arthritis & Rheumatology 2018 cited by 481

  9. Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

    Authors: Iain B. McInnes, Philip J. Mease, Bruce Kirkham, Arthur Kavanaugh, Christopher T Ritchlin, Proton Rahman, Désirée van der Heijde, R. Landewé, Philip G. Conaghan, Alice B. Gottlieb, Hanno B. Richards, Luminita Pricop, Gregory Ligozio, Manmath Patekar, Shephard Mpofu - The Lancet 2015 cited by 850

  10. Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems

    Authors: Rochelle Castillo, Ikjot Sidhu, Igor Dolgalev, Tinyi Chu, Aleksandr Prystupa, Ipsita Subudhi, Di Yan, Piotr Konieczny, Brandon Hsieh, Rebecca H. Haberman, Shanmugapriya Selvaraj, Tomoe Shiomi, Rhina Medina, Parvathy V. Girija, Adriana Heguy, Cynthia A. Loomis, Luis Chiriboga, Christopher T. Ritchlin, María de la Luz García-Hernández, John A. Carucci, S. Meehan, Andrea L. Neimann, Jóhann E. Guðjónsson, José U. Scher, Shruti Naik - Science Immunology 2023 cited by 99

  11. Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

    Authors: Iain B. McInnes, Akihiko Asahina, Laura C. Coates, Robert Landewé, Joseph F. Merola, Christopher T Ritchlin, Yoshiya Tanaka, Laure Gossec, Alice B. Gottlieb, Richard B. Warren, Barbara Ink, Deepak Assudani, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Philip J. Mease - The Lancet 2022 cited by 157

  12. Secukinumab versus adalimumab for treatment of active psoriatic arthritis (EXCEED): a double-blind, parallel-group, randomised, active-controlled, phase 3b trial

    Authors: Iain B. McInnes, Frank Behrens, Philip J. Mease, Arthur Kavanaugh, Christopher T. Ritchlin, Peter Nash, Jordi Gratacós, Philippe Goupille, Т. В. Коротаева, Alice B. Gottlieb, Ruvie Martin, Kevin Ding, Pascale Pellet, Shephard Mpofu, Luminita Pricop - The Lancet 2020 cited by 282

  13. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial

    Authors: Iain B. McInnes, Arthur Kavanaugh, Alice B. Gottlieb, L. Puig, Proton Rahman, Christopher T. Ritchlin, Carrie Brodmerkel, Shu Li, Yuhua Wang, Alan M. Mendelsohn, Mittie K. Doyle - The Lancet 2013 cited by 798

  14. IL-23 past, present, and future: a roadmap to advancing IL-23 science and therapy

    Authors: James G. Krueger, Kilian Eyerich, Vijay K. Kuchroo, Christopher T. Ritchlin, María T. Abreu, M. Merle Elloso, Anne M. Fourie, Steven Fakharzadeh, Jonathan Sherlock, Ya‐Wen Yang, Daniel J. Cua, Iain B. McInnes - Frontiers in Immunology 2024 cited by 118

  15. Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1

    Authors: Philip J. Mease, Désirée van der Heijde, Christopher T Ritchlin, Masato Okada, Raquel Cuchacovich, Catherine L Shuler, Chen‐Yen Lin, Daniel Braun, Chin H. Lee, Dafna Gladman - Annals of the Rheumatic Diseases 2016 cited by 568

  16. Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture

    Authors: Philip E. Stuart, Rajan P. Nair, Lam C. Tsoi, Trilokraj Tejasvi, Sayantan Das, Hyun Min Kang, Eva Ellinghaus, Vinod Chandran, Kristina Callis-Duffin, Robert W. Ike, Yanming Li, Xiaoquan Wen, Charlotta Enerbäck, Jóhann E. Guðjónsson, Sulev Kõks, Külli Kingo, Tõnu Esko, Ulrich Mrowietz, André Reis, Hans Wichmann, Christian Gieger, Per Hoffmann, Markus M. Nöthen, Juliane Winkelmann, Manfred Kunz, Elvia G. Moreta, Philip J. Mease, Christopher T. Ritchlin, A. Bowcock, Gerald G. Krueger, Henry W. Lim, Stephan Weidinger, Michael Weichenthal, John J. Voorhees, Proton Rahman, Peter K. Gregersen, André Franke, Dafna D. Gladman, Gonçalo R. Abecasis, James T. Elder - The American Journal of Human Genetics 2015 cited by 322

  17. Tissue-specific enhancer–gene maps from multimodal single-cell data identify causal disease alleles

    Authors: Saori Sakaue, Kathryn Weinand, Shakson Isaac, Kushal K. Dey, Karthik A. Jagadeesh, Masahiro Kanai, Gerald F. Watts, Zhu Zhu, Accelerating Medicines Partnership® RA/SLE Program and Network, Jennifer S. Albrecht, Jennifer H. Anolik, William Apruzzese, Nirmal K. Banda, Jennifer L. Barnas, Joan M. Bathon, Ami Ben‐Artzi, Brendan F. Boyce, David L. Boyle, S. Louis Bridges, Vivian P. Bykerk, Debbie Campbell, Hayley Carr, Arnold Ceponis, Adam Chicoine, Andrew Cordle, Michelle Curtis, Kevin D. Deane, Edward F. DiCarlo, Patrick Dunn, Andrew Filer, Gary S. Firestein, Lindsy Forbess, Laura Geraldino‐Pardilla, Susan M. Goodman, Ellen M. Gravallese, Peter K. Gregersen, Joel M. Guthridge, María Gutiérrez‐Arcelus, Siddarth Gurajala, V. Michael Holers, Diane Horowitz, Laura B. Hughes, Kazuyoshi Ishigaki, Lionel B. Ivashkiv, Judith A. James, A. Helena Jonsson, Joyce B. Kang, Gregory Keras, Ilya Korsunsky, Amit Lakhanpal, James A. Lederer, Zhihan J. Li, Yuhong Li, Katherine P. Liao, Arthur M. Mandelin, Ian Mantel, Mark Maybury, Joseph Mears, Nida Meednu, Nghia Millard, Larry W. Moreland, Aparna Nathan, Alessandra Nerviani, Dana E. Orange, Harris Perlman, Costantino Pitzalis, Javier Rangel‐Moreno, Deepak A. Rao, Karim Raza, Yakir Reshef, Christopher T. Ritchlin, Felice Rivellese, William H. Robinson, Laurie Rumker, Ilfita Sahbudin, Jennifer Seifert, Kamil Slowikowski, Melanie H. Smith, Darren Tabechian, Dagmar Scheel‐Toellner, Paul J. Utz, Dana Weisenfeld, Michael H. Weisman, Qian Xiao, Fan Zhang, Michael B. Brenner, Andrew McDavid, Laura T. Donlin, Kevin Wei, Alkes L. Price, Soumya Raychaudhuri - Nature Genetics 2024 cited by 51

  18. Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium

    Authors: Garrett S. Dunlap, Aaron B. Wagner, Nida Meednu, Ruoqiao Huiyi Wang, Fan Zhang, Jabea Cyril Ekabe, A. Helena Jonsson, Kevin Wei, Saori Sakaue, Aparna Nathan, Accelerating Medicines Partnership Program: Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Network, Jennifer S. Albrecht, William Apruzzese, Jennifer L. Barnas, Joan M. Bathon, Ami Ben‐Artzi, Brendan F. Boyce, S. Louis Bridges, Debbie Campbell, Hayley Carr, Arnold Ceponis, Adam Chicoine, Andrew Cordle, Michelle Curtis, Kevin D. Deane, Edward F. DiCarlo, Patrick Dunn, Lindsy Forbess, Laura Geraldino‐Pardilla, Ellen M. Gravallese, Peter K. Gregersen, Joel M. Guthridge, Diane Horowitz, Laura B. Hughes, Kazuyoshi Ishigaki, Lionel B. Ivashkiv, Judith A. James, Joyce B. Kang, Gregory Keras, Ilya Korsunsky, Amit Lakhanpal, James A. Lederer, Yuhong Li, Zhihan J. Li, Katherine P. Liao, Holden Maecker, Arthur M. Mandelin, Ian Mantel, Mark Maybury, Mandy J. McGeachy, Joseph Mears, Alessandra Nerviani, Dana E. Orange, Harris Perlman, Javier Rangel‐Moreno, Karim Raza, Yakir Reshef, Christopher T. Ritchlin, Felice Rivellese, William H. Robinson, Laurie Rumker, Ilfita Sahbudin, Karen Salomon-Escoto, Dagmar Scheel‐Toellner, Jennifer Seifert, Anvita Singaraju, Melanie H. Smith, Paul J. Utz, Kathryn Weinand, Dana Weisenfeld, Michael H. Weisman, Qian Xiao, Zhu Zhu, Vivian P. Bykerk, Laura T. Donlin, Susan M. Goodman, Gary S. Firestein, David L. Boyle, V. Michael Holers, Larry W. Moreland, Darren Tabechian, Costantino Pitzalis, Andrew Filer, Soumya Raychaudhuri, Michael B. Brenner, Juilee Thakar, Andrew McDavid, Deepak A. Rao, Jennifer H. Anolik - Nature Communications 2024 cited by 53

  19. Granzyme K activates the entire complement cascade

    Authors: C. Donado, Erin Theisen, Fan Zhang, Aparna Nathan, Madison L. Fairfield, Karishma Vijay Rupani, Dominique Jones, Kellsey Johannes, Accelerating Medicines Partnership RA/SLE Network, Jennifer S. Albrecht, Jennifer H. Anolik, William Apruzzese, Jennifer L. Barnas, Joan M. Bathon, Ami Ben‐Artzi, Brendan F. Boyce, David L. Boyle, S. Louis Bridges, Vivian P. Bykerk, Debbie Campbell, Arnold Ceponis, Adam Chicoine, Michelle Curtis, Kevin D. Deane, Edward F. DiCarlo, Laura T. Donlin, Patrick Dunn, Andrew Filer, Hayley Carr, Gary S. Firestein, Lindsy Forbess, Laura Geraldino‐Pardilla, Susan M. Goodman, Ellen M. Gravallese, Deepak A. Rao, Peter K. Gregersen, Joel M. Guthridge, María Gutiérrez‐Arcelus, V. Michael Holers, Diane Horowitz, Laura B. Hughes, Lionel B. Ivashkiv, Kazuyoshi Ishigaki, Judith A. James, Joyce B. Kang, Gregory Keras, Amit Lakhanpal, James A. Lederer, Myles Lewis, Yuhong Li, Katherine P. Liao, Arthur M. Mandelin, Ian Mantel, Kathryne E. Marks, Mark Maybury, Andrew McDavid, Mandy J. McGeachy, Joseph Mears, Nida Meednu, Nghia Millard, Larry W. Moreland, Saba Nayar, Alessandra Nerviani, Dana E. Orange, Harris Perlman, Costantino Pitzalis, Javier Rangel‐Moreno, Karim Raza, Yakir Reshef, Christopher T. Ritchlin, Felice Rivellese, William H. Robinson, Laurie Rumker, Ilfita Sahbudin, Saori Sakaue, Jennifer Seifert, Dagmar Scheel‐Toellner, Anvita Singaraju, Kamil Slowikowski, Melanie H. Smith, Darren Tabechian, Paul J. Utz, Kathryn Weinand, Dana Weisenfeld, Michael H. Weisman, Qian Xiao, Zhu Zhu, Zhihan J. Li, Andrew Cordle, Aaron Wyse, Soumya Raychaudhuri, Daniel F. Dwyer, A. Helena Jonsson, Michael B. Brenner - Nature 2025 cited by 109

  20. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

    Authors: Laura C. Coates, Arthur Kavanaugh, Philip J. Mease, Enrique R. Soriano, Maria Laura Acosta‐Felquer, April W. Armstrong, Wilson Bautista‐Molano, Wolf‐­Henning Boehncke, Willemina Campbell, Alberto Cauli, Luis R. Espinoza, Oliver FitzGerald, Dafna D. Gladman, Alice B. Gottlieb, Philip Helliwell, M. Elaine Husni, Þorvarður Jón Löve, Ennio Lubrano, Neil McHugh, Peter Nash, Alexis Ogdie, Ana‐Maria Orbai, Andrew Parkinson, Denis O’Sullivan, Cheryl F. Rosen, Sergio Schwartzman, Evan Siegel, Sergio Toloza, William Tuong, Christopher T. Ritchlin - Arthritis & Rheumatology 2016 cited by 904

  21. Does biologic therapy impact the development of PsA among patients with psoriasis?

    Authors: Elana Meer, Joseph F. Merola, Robert Fitzsimmons, Þorvarður Jón Löve, Shiyu Wang, Daniel B. Shin, Yong Chen, Sharon X. Xie, Hyon K. Choi, Yuqing Zhang, José U. Scher, Christopher T. Ritchlin, Joel M. Gelfand, Alexis Ogdie - Annals of the Rheumatic Diseases 2022 cited by 69

  22. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double‐blind, randomized, placebo‐controlled trial

    Authors: Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin, Eric Ruderman, Serge Steinfeld, Ernest Choy, John T. Sharp, P A Ory, Renee Perdok, Mark Weinberg - Arthritis & Rheumatism 2005 cited by 905

  23. Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phase 3, multicentre, double-blind, placebo-controlled, randomised PSUMMIT 2 trial

    Authors: Christopher T. Ritchlin, Proton Rahman, Arthur Kavanaugh, Iain B. McInnes, L. Puig, Shu Li, Yuhua Wang, Yaung‐Kaung Shen, Mittie K. Doyle, Alan M. Mendelsohn, Alice B. Gottlieb, Michelle Perate, Mary Whitman, Lisa T Dooley, R Alten, C Birbara, E Boh, J Braun, J Budd, C Chattapadhyay, D Chudzik, P Claudepierre, R Cooper, E Drescher, J Dutz, C Edwards, B Elewski, H El-Kadi, L Erlacher, R Flipo, SA Fretzin, E George, G Gladstein, RM Griffin, MW Grisanti, L Guenther, W Gulliver, K Hobbs, E Huang, E Ilivanova, S Jeka, M Khraishi, M Kokhan, N Korman, R Kunynetz, CL Leonardi, C Lessard, U Lindquist, A Martin, RT Matheson, FT Murphy, E Nasonov, W Palmer, K Papp, J Rech, M Rell-Bakalarska, P Rich, C Rosen, A Rudin, A Ruppert-Roth, C Scheinecker, S Seigel, S Shaikh, T Sheeran, WJ Shergy, EL Siegel, S Sierakowski, H Sofen, S Szanto, H Tahir, E Telegdy, D Toth, D Walker, AG Wilson, M Witt, J Wollenhaupt, D Zoschke, A Zubrzycka - Annals of the Rheumatic Diseases 2014 cited by 658

  24. Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis

    Authors: Zilong Bai, Nicholas Bartelo, Maryam Aslam, Elisabeth A. Murphy, Caryn Hale, Nathalie E. Blachère, Salina Parveen, Edoardo Spolaore, Edward F. DiCarlo, Ellen M. Gravallese, Melanie H. Smith, Accelerating Medicines Partnership RA/SLE Network, Mayu O. Frank, Caroline S. Jiang, Haotan Zhang, Christina Pyrgaki, Myles Lewis, Shafaq Sikandar, Costantino Pitzalis, Joseph B. Lesnak, Khadijah Mazhar, Theodore J. Price, Anne‐Marie Malfait, Rachel E. Miller, Fan Zhang, Susan M. Goodman, Robert B. Darnell, Fei Wang, Dana E. Orange, Jennifer S. Albrecht, Jennifer H. Anolik, William Apruzzese, Brendan F. Boyce, David L. Boyle, Michael B. Brenner, S. Louis Bridges, Christopher D. Buckley, Jane H. Buckner, Vivian P. Bykerk, James P. Dolan, Laura T. Donlin, Andrew Filer, Gary S. Firestein, Chamith Y. Fonseka, Peter K. Gregersen, Joel M. Guthridge, María Gutiérrez‐Arcelus, V. Michael Holers, Laura B. Hughes, Lionel B. Ivashkiv, Eddie A. James, Judith A. James, A. Helena Jonsson, Stephen Kelly, James A. Lederer, Yvonne Lee, Arthur M. Mandelin, Mandy J. McGeachy, Joseph Mears, Nida Meednu, Larry W. Moreland, Harris Perlman, Javier Rangel‐Moreno, Deepak A. Rao, Soumya Raychaudhuri, Christopher T. Ritchlin, William H. Robinson, Mina Rohani‐Pichavant, Jennifer Seifert, Kamil Slowikowski, Darren Tabechian, Paul J. Utz, Gerald F. Watts, Kevin Wei - Science Translational Medicine 2024 cited by 66